| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |